Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-11-22FDA Approved: CEFIXIME — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for cefixime. This action updates the cefixime NDA, potentially expanding i…
-
FDA approval · 2013-06-05FDA Approved: LEVOFLOXACIN — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's Original Application for levofloxacin (generic), granting clearance for a generic version of th…
-
FDA approval · 2012-12-18FDA Approved: AZITHROMYCIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for azithromycin submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2012-07-25FDA Approved: CLARITHROMYCIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a generic clarithromycin product under an original ANDA from Rising Pharma Holdings, Inc.
-
FDA approval · 2012-03-30FDA Approved: LEVOFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved an original ANDA for Levofloxacin, a generic antibiotic, submitted by Chartwell RX, LLC. The approval enables a generic version…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-02-17FDA Approved: ERTAPENEM — Supplemental Application (ENDO USA, Inc.)
FDA approved a supplemental application for ertapenem (ertapenem sodium) filed by ENDO USA, Inc. This action updates regulatory status for t…
-
FDA approval · 2012-01-20FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of amoxicillin and clavulanate potassium from Aurobindo Pharma Limited under an Original Application (ANDA 09…
-
FDA approval · 2012-01-20FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for amoxicillin and clavulanate potassium, authorizing the marketing of thi…
-
FDA approval · 2011-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium (Hikma Pharmaceuticals USA Inc.), updating the product…
-
FDA approval · 2010-12-22FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for clarithromycin by Sandoz Inc., confirming the approval of a generic clarithromycin product under…
-
FDA approval · 2010-10-29FDA Approved: TEFLARO — Original Application (Allergan, Inc.)
FDA approved TEFLARO (ceftaroline fosamil) under an original NDA (NDA 200327) from Allergan for the treatment of acute bacterial skin and sk…
-
FDA approval · 2009-05-14FDA Approved: CEFDINIR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for CEFDINIR (cefdinir) submitted by Sandoz Inc.
-
FDA approval · 2009-03-05FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Amoxicillin and Clavulanate Potassium, a generic antibiotic (…
-
FDA approval · 2009-03-04FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approves a supplemental application for Clarithromycin from Sandoz Inc, granting approval to a generic version under an ANDA.
-
FDA approval · 2008-09-18FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Clarithromycin from Sandoz Inc, marking regulatory clearance for changes to this generic ant…
-
FDA approval · 2008-07-23FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for cefdinir (CEFDINIR). The approval authorizes changes to the cefdi…
-
FDA approval · 2008-06-12FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA has approved a supplemental application for cefdinir (Teva), updating the labeling for the product. This action confirms a labeling-rela…
-
FDA approval · 2008-06-11FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for CEFDINIR (cefdinir) from Lupin Pharmaceuticals, indicating an expanded approval for this antibio…
-
FDA approval · 2008-01-07FDA Approved: CEFDINIR — Original Application (BluePoint Laboratories)
FDA approves an Abbreviated New Drug Application for cefdinir from BluePoint Laboratories, indicating the availability of a generic cefdinir…
-
FDA approval · 2007-12-14FDA Approved: CEFDINIR — Original Application (Aurobindo Pharma Limited)
FDA approved a generic cefdinir (CEFDINIR) from Aurobindo Pharma Limited under an Original Application (ANDA) for acute otitis media, acute …
-
FDA approval · 2007-11-09FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s generic amoxicillin and clavulanate potassium under an Original Application.
-
FDA approval · 2007-10-17FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Clarithromycin submitted by Sandoz Inc, granting a supplemental approval for the product.
-
FDA approval · 2007-09-07FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for cefdinir, updating the approved labeling for the product.
-
FDA approval · 2007-08-20FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)
FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).
-
FDA approval · 2007-08-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's amoxicillin/clavulanate potassium as an Original Application (ANDA), granting approval for a generic antibiotic pr…